» Authors » Jee Hyun Kim

Jee Hyun Kim

Explore the profile of Jee Hyun Kim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 502
Citations 8322
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Choi J, Park W, Kang M, Seo J, Jung E, et al.
Cancer Res Treat . 2025 Mar; PMID: 40083083
Purpose: Older cancer patients face unique challenges due to age-related physiological changes, increasing their vulnerability to treatment-related toxicities. Geriatric assessment (GA) is a validated tool for optimizing care, yet there...
2.
Kim J, Lee J, Kim D, Yang Y, Cho S, Park H, et al.
Animals (Basel) . 2025 Feb; 15(4). PMID: 40003056
Non-invasive genetic approaches, particularly using fecal samples, are commonly used to study endangered and elusive species, as they are easy to collect with minimal permission and cause little disturbance to...
3.
Khan R, Turner A, Berk M, Walder K, Rossell S, Guerin A, et al.
Biomolecules . 2025 Feb; 15(2). PMID: 40001609
Methamphetamine use disorder is a pressing global health issue, often accompanied by significant cognitive deficits that impair daily functioning and quality of life and complicate treatment. Emerging evidence highlights the...
4.
Ahn H, Kim J, Lee K, Kim G, Kang S, Lee K, et al.
Lancet Oncol . 2025 Feb; 26(3):343-354. PMID: 39978378
Background: The phase 2 randomised Young-PEARL study demonstrated that palbociclib plus exemestane with ovarian function suppression significantly prolonged progression-free survival compared with capecitabine in premenopausal women with hormone receptor-positive, HER2-negative...
5.
Luikinga S, Madsen H, Zbukvic I, Perry C, Lawrence A, Kim J
Drug Alcohol Depend . 2025 Feb; 269:112599. PMID: 39978281
Adolescence is the most vulnerable period for developing substance use disorders, with adolescents relapsing more compared to adults even after therapy. Methamphetamine is a widely-used illicit psychostimulant by adolescents that...
6.
Kim J, Walder K, Panizzutti B, Williams L, Berk M
Biol Psychiatry . 2025 Feb; PMID: 39954921
No abstract available.
7.
Kong S, Park S, Kim J, Kim S, Kim S, Kim J, et al.
Endocrinol Metab (Seoul) . 2025 Feb; PMID: 39901808
Background: Hypercalcemia of malignancy (HCM), a major metabolic complication of cancer, is often managed with bisphosphonates (BP) and, increasingly, with denosumab. We aimed to compare the effectiveness and safety of...
8.
Panizzutti B, Bortolasci C, Spolding B, Kidnapillai S, Connor T, Truong T, et al.
World J Biol Psychiatry . 2025 Jan; 26(3):146-152. PMID: 39846496
Objectives: This study aimed to explore the impact of pharmacological treatments used for bipolar disorder and schizophrenia on the expression of genes involved in the focal adhesion pathway, addressing a...
9.
Kim J, Na H, Lee S, Kim J, Suh K, Kim S, et al.
Sci Rep . 2025 Jan; 15(1):2171. PMID: 39820489
Next-generation sequencing (NGS) cancer profiling has gained traction in routine clinical practice in South Korea. Here, we evaluated the use of NGS testing and genomically-matched therapies for patients with advanced...
10.
Park J, Shin H, Kim M, Kim Y, Ryu W, Kim E, et al.
J Clin Sleep Med . 2025 Jan; PMID: 39815737
Study Objectives: Undiagnosed or untreated moderate to severe obstructive sleep apnea (OSA) increases cardiovascular risks and mortality. Early and efficient detection is critical, given its high prevalence. We aimed to...